Topic 1 Nbns2213
Topic 1 Nbns2213
Topic 1 Nbns2213
3. Secondary Hemostasis: It involves the coagulation cascade, a series of enzymatic reactions that lead to
the formation of a stable blood clot.
a. Intrinsic and Extrinsic Pathways: The coagulation cascade can be initiated through the intrinsic or
extrinsic pathways
-The intrinsic pathway is activated by factors within the blood and is triggered when blood contacts a
foreign surface, like collagen exposed during injury.
- The extrinsic pathway is initiated by tissue factor (TF), which is released from damaged tissues outside
the blood vessel.
b. Common Pathway: Both pathways converge into a common pathway, where several clotting factors,
such as Factor X and Factor II (prothrombin), interact in a series of reactions.
c. Formation of Thrombin: The common pathway ultimately leads to the activation of prothrombin into
thrombin by Factor Xa and Factor Va, among other factors.
Cont’ Sequence of events in the process
of blood clotting
4. Thrombin Activation: Thrombin (enzyme in blood clotting) converts soluble
fibrinogen into insoluble fibrin that forms a mesh-like structure that traps blood
cells and reinforces the platelet plug to create a stable clot.
5. Fibrin Formation: Fibrin strands continue to polymerize and create a meshwork, which
\ traps more platelets, red blood cells and other components of blood to form a solid clot.
6. Clot Retraction: After clot formation, the clot contracts and becomes denser to
further seal the injury site.
7. Platelet Release: As the clot forms and stabilizes, platelets release additional factors that
promote clot formation and wound healing.
8. Clot Dissolution: Once the injury is repaired, the clot is no longer needed. A process called
fibrinolysis begins, in which plasmin breaks down fibrin strands, leading to the dissolution of
the clot.
Anatomy & Physiology of the
Lymphatic System
◦ The lymphatic system is a network of vessels, nodes and organs responsible for maintaining
fluid balance, filtering foreign substances and pathogens and supporting the immune system.
Key components include:
1. Lymph Nodes: These small, bean-shaped structures filter lymph fluid for pathogens and
abnormal cells, initiating an immune response when needed.
2. Lymphatic Vessels: These vessels transport lymphatic fluid with white blood cells, proteins
and waste products.
3. Spleen: The spleen filters blood, removing damaged blood cells and storing platelets.
4. Thymus Gland: This gland plays a vital role in immune system development, particularly in
early life
5. Tonsils and Adenoids: These tissues help defend against infections by trapping and
destroying pathogens.
Data obtained on assessment of patient with hematological
or lymphatic disorder
◦ Assessing is a crucial step in diagnosing and managing their condition.
◦ Here's a list of key data that should be obtained during the assessment :
1.Medical History:
-Age, gender and ethnicity.
-Chief complaint and reason for seeking medical attention.
-Medical and surgical history.
-Family history of hematological or genetic disorders.
-Medication history, including any current or recent use of anticoagulants or medications that can
affect blood or lymphatic function.
-Allergies and drug sensitivities.
-Social history including tobacco and alcohol use and exposure to environmental toxins.
Cont’ Data obtained on assessment of patient with
hematological or lymphatic disorder
2. Symptoms and Presenting Complaints:
-Specific hematological or lymphatic symptoms such as bleeding, bruising, petechiae,
pallor,
fatigue, lymph node enlargement or unexplained weight loss.
-Pain or discomfort in the abdomen, bones or joints.
-Any signs of infection or immune-related symptoms.
3. Physical Examination:
-General appearance and vital signs.
-Examination of the skin, looking for signs of pallor, rashes or petechiae.
-Palpation of lymph nodes for size, tenderness and consistency.
-Examination of the abdomen for organomegaly (enlarged liver or spleen).
-Assessment of the musculoskeletal system for joint pain or swelling.
-Neurological examination if there are signs of neurological involvement.
Cont’ Data obtained on assessment of patient with
hematological or lymphatic disorder
4. Laboratory and Diagnostic Tests:
-Complete Blood Count to assess red blood cells, white blood cell and platelets
-Peripheral blood smear to evaluate blood cell morphology.
-Coagulation profile including prothrombin time (PT), activated partial thromboplastin time (aPTT) and
international normalized ratio (INR).
-Bone marrow aspiration and biopsy to assess the cellular composition of the bone marrow.
-Genetic testing or molecular studies to identify specific genetic mutations associated with hematological
disorders.
-Serum chemistry panel to evaluate organ function and electrolyte levels.
-Flow cytometry or immunophenotyping to characterize abnormal lymphoid populations.
-Coagulation factor assays if bleeding disorders are suspected.
-Hemoglobin electrophoresis to diagnose hemoglobinopathies like sickle cell disease or thalassemia.
-Radiological studies (e.g., ultrasound, CT, MRI) to assess lymph node or organ involvement.
Cont’ Data obtained on assessment of patient with hematological or
lymphatic disorder
5. Specialized Hematological Tests:
-Hemoglobin A1c for diabetes monitoring.
-Iron studies (serum iron, ferritin, transferrin saturation) to evaluate iron metabolism.
-Coombs test (direct and indirect) to assess for hemolytic anemias.
-Thrombophilia screening for clotting disorders.
-Tests for specific markers or proteins associated with hematological malignancies (e.g., leukemia, lymphoma).
6. Assessment of Bone Marrow Function:
-Assessing bone marrow function including the production of blood cells in certain cases.
7. Psychosocial Assessment:
-Assess the patient's emotional and psychological well-being as living these disorders can be emotionally challenging.
8. Consultation with Specialists:
- Depending on the specific disorder, the patient may need referrals to hematologists, oncologists or other specialists
for further evaluation and management.
A comprehensive assessment of patients with hematological or lymphatic disorders is crucial for accurate diagnosis
and appropriate management. Treatment options and prognosis often depend on identifying the underlying cause and
the extent of organ involvementt.
Laboratory and diagnostic studies used in evaluation of the hematological and lymphatic system